Education
About Us
Working with TipRanks
Follow Us
Long-term Stock Picks - New Portfolio
TJ Lawless
Long-term Stock PicksIndividual Investor
Ranked #480,407 out of 824,962 TipRanks' Investors
Success Rate
180 out of 452
profitable transactions
profitable transactions
Average Return
16.71%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 11.45%
6-Month Return▲ 130.52%
12-Month Return▲ 125.99%
YTD Return▲ 137.57%
Total Return▲ 147.04%
Best Trade
Bio
Biotech companies with great long-term growth prospects
Performance
43.98%0-43.98%
▼ 6.38%
▼ 5.57%
▼ 11.67%
Mar 2025
▲ 0.80%
▼ 0.87%
▲ 20.49%
Apr 2025
▲ 11.63%
▲ 6.28%
▲ 1.92%
May 2025
▲ 9.25%
▲ 5.14%
▲ 10.82%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 19.46%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 43.98%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 8.67%
Sep 2025
▲ 4.39%
▲ 0.84%
▲ 6.82%
Oct 2025
▼ 6.38%▼ 5.57%▼ 11.67%
▲ 0.80%▼ 0.87%▲ 20.49%
▲ 11.63%▲ 6.28%▲ 1.92%
▲ 9.25%▲ 5.14%▲ 10.82%
▲ 7.60%▲ 2.30%▲ 19.46%
▲ 2.76%▲ 2.05%▲ 43.98%
▲ 12.88%▲ 3.56%▲ 8.67%
▲ 4.39%▲ 0.84%▲ 6.82%
Recent Activity
Durect
―
▼ 68.48%
2
Close
Sep 11, 2025
DermTech
―
▼ 99.80%
3
Close
Aug 13, 2025
IGM Biosciences
―
▼ 88.73%
2
Close
Aug 13, 2025
Verve Therapeutics
―
▲ 9.91%
4
Close
Jul 24, 2025
Arcus Biosciences
6.46%
▼ 2.88%
3
Buy
Jun 01, 2025
Denali Therapeutics
1.49%
▼ 34.00%
5
Buy
Jun 01, 2025
Ionis Pharmaceuticals
3.93%
▲ 109.62%
1
Open
Jun 01, 2025
Ultragenyx Pharmaceutical
0.93%
▼ 6.95%
1
Open
Jun 01, 2025
Akero Therapeutics
―
▲ 178.13%
4
Close
May 24, 2025
Pfizer
6.79%
▲ 34.18%
5
Open
May 10, 2025
Inmune Bio
1.18%
▼ 81.37%
4
Buy
May 10, 2025
Iovance Biotherapeutics
0.36%
▼ 38.49%
2
Buy
May 10, 2025
AnaptysBio
3.74%
▲ 64.57%
2
Buy
May 10, 2025
Stoke Therapeutics
0.35%
▲ 228.05%
1
Open
May 10, 2025
Altimmune
4.36%
▲ 86.86%
12
Buy
May 07, 2025
Viking Therapeutics
2.8%
▲ 387.75%
7
Buy
May 03, 2025
Ero Copper
1.69%
▲ 40.48%
2
Buy
May 03, 2025
Recursion Pharmaceuticals
0.16%
▼ 0.52%
1
Open
Apr 11, 2025
Gritstone bio
―
▼ 99.74%
5
Close
Apr 07, 2025
SilverCrest Metals
―
▲ 67.39%
2
Close
Feb 13, 2025